Kume N, Hayashida K, Nakanishi N, Cho I, Suga K, Matsunaga N
Department of Radiology, National Cardiovascular Center, Osaka, Japan.
Nucl Med Commun. 1999 Mar;20(3):247-53. doi: 10.1097/00006231-199903000-00007.
We report on six patients with chronic pulmonary embolism who underwent 123I-IMP and 99Tcm-MAA lung SPET before and after thromboendarterectomy. 123I-IMP lung SPET can assess the viability of lung parenchyma, because it is a non-particulate agent that accumulates in the endothelial membranes of pulmonary capillaries. Chronic pulmonary thromboembolism accompanied by pulmonary hypertension has a poor prognosis that may be improved only by thromboendarterectomy. We compared 123I-IMP and 99Tcm-MAA lung SPET in terms of functional improvement after such surgery. After thromboendarterectomy, all six patients were functionally improved, according to the criteria of the New York Heart Association. The pre- and post-surgery percentage of vascular obstruction did not differ significantly with 99Tcm-MAA lung SPET (44.8 +/- 11.2% and 32.5 +/- 15.6% pre- and post-surgery, respectively). In contrast, 123I-IMP lung SPET revealed a significant pre- versus post-surgery difference (15.5 +/- 9.5% and 3.3 +/- 5.9% pre- and post-surgery, respectively). 123I-IMP lung SPET could be useful for evaluating thromboendarterectomy because pulmonary parenchymal viability owing to arterial microvasculature can be estimated.
我们报告了6例慢性肺栓塞患者,他们在血栓内膜剥脱术前和术后接受了123I-异丁基苄胍(123I-IMP)和99锝-大颗粒聚合白蛋白(99Tcm-MAA)肺单光子发射计算机断层显像(SPET)检查。123I-IMP肺SPET可评估肺实质的活力,因为它是一种非颗粒性药物,可积聚在肺毛细血管的内皮膜中。伴有肺动脉高压的慢性肺血栓栓塞症预后较差,可能只有通过血栓内膜剥脱术才能改善。我们比较了123I-IMP和99Tcm-MAA肺SPET在此类手术后的功能改善情况。根据纽约心脏协会的标准,血栓内膜剥脱术后,所有6例患者的功能均得到改善。99Tcm-MAA肺SPET显示手术前后血管阻塞的百分比无显著差异(术前44.8±11.2%,术后32.5±15.6%)。相比之下,123I-IMP肺SPET显示手术前后有显著差异(术前15.5±9.5%,术后3.3±5.9%)。123I-IMP肺SPET可用于评估血栓内膜剥脱术,因为可以估计动脉微脉管系统所致的肺实质活力。